ArcCHECK系统在食管癌断层治疗方案验证中的应用

Zhenli Wang, A. Zheng, Jian Zhu, H. Du, Xiaodong Sun, Dong Wang, Huitao Wang, Yaowen Zhang, Qingshan Zhu, Z. Cui
{"title":"ArcCHECK系统在食管癌断层治疗方案验证中的应用","authors":"Zhenli Wang, A. Zheng, Jian Zhu, H. Du, Xiaodong Sun, Dong Wang, Huitao Wang, Yaowen Zhang, Qingshan Zhu, Z. Cui","doi":"10.3760/CMA.J.CN113030-20181221-00005","DOIUrl":null,"url":null,"abstract":"Objective \nTo explore the application of ArcCheck system in the validation of Helical and Direct tomotherapy plans for esophageal cancer and summarize relevant experience. \n \n \nMethods \nThe Helical and Direct tomotherapy verification plans were established for 32 patients with esophageal cancer at different positions according to the doctor′s instructions, which were verified by the ArcCHECK system to compare the passing rate of the results.The correlation between the volume of the target area and the passing rate of the planned verification was analyzed. The therapeutic verification plan with a small target volume was made. The target area was placed at the center of ArcCHECK phantom and the area of detectors to statistically compare the verification passing rates. \n \n \nResults \nHelical plan showed a significantly higher passing rate than the Direct plan (P 0.05). \n \n \nConclusions \nThe passing rate of the Helical plan is generally higher than that of the Direct plan, which may be related to the angular response of the ArcCHECK detector and the fact that more reference points are not included for calculation due to low-dose radiation. In addition, it may also be related to the higher requirements of Direct plan for tomotherapy dose control system. In the Helical verification plan, when the 3%/3mm criterion is adopted, the larger the target volume, the higher the possibility of lower passing rate, whereas the correlation coefficient between them is relatively low. The high-dose area can be verified by the plans at the center of the phantom or the detection point. With the comprehensive consideration, we suggest putting it at the center of the phantom. \n \n \nKey words: \nEsophageal neoplasm/helical tomotherapy; ArcCHECK system; Plan verification; Quality assurance","PeriodicalId":10288,"journal":{"name":"中华放射肿瘤学杂志","volume":"29 1","pages":"273-277"},"PeriodicalIF":0.0000,"publicationDate":"2020-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Application of ArcCHECK system in the verification of tomotherapy plan for esophageal cancer\",\"authors\":\"Zhenli Wang, A. Zheng, Jian Zhu, H. Du, Xiaodong Sun, Dong Wang, Huitao Wang, Yaowen Zhang, Qingshan Zhu, Z. Cui\",\"doi\":\"10.3760/CMA.J.CN113030-20181221-00005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective \\nTo explore the application of ArcCheck system in the validation of Helical and Direct tomotherapy plans for esophageal cancer and summarize relevant experience. \\n \\n \\nMethods \\nThe Helical and Direct tomotherapy verification plans were established for 32 patients with esophageal cancer at different positions according to the doctor′s instructions, which were verified by the ArcCHECK system to compare the passing rate of the results.The correlation between the volume of the target area and the passing rate of the planned verification was analyzed. The therapeutic verification plan with a small target volume was made. The target area was placed at the center of ArcCHECK phantom and the area of detectors to statistically compare the verification passing rates. \\n \\n \\nResults \\nHelical plan showed a significantly higher passing rate than the Direct plan (P 0.05). \\n \\n \\nConclusions \\nThe passing rate of the Helical plan is generally higher than that of the Direct plan, which may be related to the angular response of the ArcCHECK detector and the fact that more reference points are not included for calculation due to low-dose radiation. In addition, it may also be related to the higher requirements of Direct plan for tomotherapy dose control system. In the Helical verification plan, when the 3%/3mm criterion is adopted, the larger the target volume, the higher the possibility of lower passing rate, whereas the correlation coefficient between them is relatively low. The high-dose area can be verified by the plans at the center of the phantom or the detection point. With the comprehensive consideration, we suggest putting it at the center of the phantom. \\n \\n \\nKey words: \\nEsophageal neoplasm/helical tomotherapy; ArcCHECK system; Plan verification; Quality assurance\",\"PeriodicalId\":10288,\"journal\":{\"name\":\"中华放射肿瘤学杂志\",\"volume\":\"29 1\",\"pages\":\"273-277\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-04-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华放射肿瘤学杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.CN113030-20181221-00005\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华放射肿瘤学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.CN113030-20181221-00005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的探讨ArcCheck系统在食管癌螺旋和直接断层治疗方案验证中的应用,总结相关经验。方法对32例食管癌患者按医嘱在不同部位建立螺旋和直接断层治疗验证方案,并通过ArcCHECK系统进行验证,比较结果的通过率。分析了靶区体积与计划验证通过率之间的关系。制定了小靶体积的治疗验证方案。将目标区域置于ArcCHECK幻影和检测器区域的中心,统计比较验证通过率。结果螺旋计划的通过率明显高于直接计划(p0.05)。结论螺旋方案的通过率普遍高于直接方案,这可能与ArcCHECK探测器的角度响应以及由于低剂量辐射而没有纳入更多参考点计算有关。此外,也可能与Direct plan对断层治疗剂量控制系统的要求较高有关。在螺旋验证方案中,当采用3%/3mm准则时,目标体积越大,低通过率的可能性越大,两者之间的相关系数相对较低。高剂量区域可以通过幻影中心或检测点的平面图进行验证。综合考虑,我们建议把它放在幻影的中心。关键词:食管肿瘤/螺旋断层治疗;ArcCHECK系统;验证计划;质量保证
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Application of ArcCHECK system in the verification of tomotherapy plan for esophageal cancer
Objective To explore the application of ArcCheck system in the validation of Helical and Direct tomotherapy plans for esophageal cancer and summarize relevant experience. Methods The Helical and Direct tomotherapy verification plans were established for 32 patients with esophageal cancer at different positions according to the doctor′s instructions, which were verified by the ArcCHECK system to compare the passing rate of the results.The correlation between the volume of the target area and the passing rate of the planned verification was analyzed. The therapeutic verification plan with a small target volume was made. The target area was placed at the center of ArcCHECK phantom and the area of detectors to statistically compare the verification passing rates. Results Helical plan showed a significantly higher passing rate than the Direct plan (P 0.05). Conclusions The passing rate of the Helical plan is generally higher than that of the Direct plan, which may be related to the angular response of the ArcCHECK detector and the fact that more reference points are not included for calculation due to low-dose radiation. In addition, it may also be related to the higher requirements of Direct plan for tomotherapy dose control system. In the Helical verification plan, when the 3%/3mm criterion is adopted, the larger the target volume, the higher the possibility of lower passing rate, whereas the correlation coefficient between them is relatively low. The high-dose area can be verified by the plans at the center of the phantom or the detection point. With the comprehensive consideration, we suggest putting it at the center of the phantom. Key words: Esophageal neoplasm/helical tomotherapy; ArcCHECK system; Plan verification; Quality assurance
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
6375
期刊介绍: The Chinese Journal of Radiation Oncology is a national academic journal sponsored by the Chinese Medical Association. It was founded in 1992 and the title was written by Chen Minzhang, the former Minister of Health. Its predecessor was the Chinese Journal of Radiation Oncology, which was founded in 1987. The journal is an authoritative journal in the field of radiation oncology in my country. It focuses on clinical tumor radiotherapy, tumor radiation physics, tumor radiation biology, and thermal therapy. Its main readers are middle and senior clinical doctors and scientific researchers. It is now a monthly journal with a large 16-page format and 80 pages of text. For many years, it has adhered to the principle of combining theory with practice and combining improvement with popularization. It now has columns such as monographs, head and neck tumors (monographs), chest tumors (monographs), abdominal tumors (monographs), physics, technology, biology (monographs), reviews, and investigations and research.
期刊最新文献
Current situation and research progress on postoperative adjuvant radiotherapy for thymoma Mechanism of radiation combined with recombinant human endostatin in inducing myocardial fibrosis The diagnostic value of HPV detection in squamous cell carcinoma of cervical lymph node metastasis from an unknown primary site (with report of 6 cases) Application of ArcCHECK system in the verification of tomotherapy plan for esophageal cancer Current situation of clinical research of buccal mucosa squamous cell carcinoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1